Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Physics

Quantum Mechanics

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1016/s1470-2045(11)70293-5

License

CC-BY

Other Formats

PDF